Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02905461
Other study ID # 10831
Secondary ID
Status Completed
Phase N/A
First received September 14, 2016
Last updated February 6, 2018
Start date December 8, 2016
Est. completion date January 31, 2018

Study information

Verified date September 2017
Source London School of Hygiene and Tropical Medicine
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This randomised controlled trial will establish the effect a contraceptive intervention delivered by mobile phone text message on the acceptability of effective contraception in Palestine. Woman aged 18-24 will be randomised to receive 0-3 text messages a day for 4 months (intervention) or a monthly text message not about contraception (control). Participants will complete a questionnaire at baseline and 4 month follow-up.


Recruitment information / eligibility

Status Completed
Enrollment 586
Est. completion date January 31, 2018
Est. primary completion date January 31, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 24 Years
Eligibility Inclusion Criteria:

- Aged 18-24 years

- Own a personal mobile phone

- Not using the pill, implant, injection, intrauterine device or patch

- Live in the West Bank

Exclusion Criteria:

- Cannot read Arabic

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Contraceptive text messages

Other:
Text messages not about contraception


Locations

Country Name City State
Palestinian Territory, occupied Palestinian Family Planning and Protection Association Jerusalem

Sponsors (3)

Lead Sponsor Collaborator
London School of Hygiene and Tropical Medicine International Planned Parenthood Federation, Palestinian Family Planning and Protection Association

Country where clinical trial is conducted

Palestinian Territory, occupied, 

Outcome

Type Measure Description Time frame Safety issue
Other Knowledge of effective contraception Score on the knowledge measure 4 months
Other Perceived norms in relation to using and communicating with partners about contraception Responses to the perceived norms scales 4 months
Other Personal agency in using and communicating with partners about contraception Responses to the personal agency scales 4 months
Other Intention to use effective contraception Response to the intention scale 4 months
Other Intervention 'dose' received If participants read all, some, most or none of the messages and if they stopped the messages 4 months
Primary Acceptability of at least one method of effective contraception The proportion reporting that at least one method of effective contraception is acceptable (pill, intrauterine device, injection, implant, patch) 4 months
Secondary Use of effective contraception The proportion reporting current use of effective contraception (pill, intrauterine device, injection, implant, patch) 4 months
Secondary Acceptability of individual effective contraceptive methods The proportion reporting that individual methods of effective contraception are acceptable (pill, intrauterine device, injection, implant, patch) 4 months
Secondary Discontinuation of effective contraception The proportion reporting use of effective contraception at any time during the 4 months (pill, intrauterine device, injection, implant, patch) 4 months
Secondary Service uptake The proportion reporting attending a sexual health service during the 4 months 4 months
Secondary Unintended pregnancy The proportion reporting that they became pregnant and did not want to become pregnant during the study 4 months
Secondary Induced abortion The proportion reporting having an abortion during the study 4 months
See also
  Status Clinical Trial Phase
Completed NCT02577601 - Impact of Combined Hormonal Contraceptives on UPA Phase 4
Completed NCT03153644 - Improving Contraceptive Care for Women With Medical Conditions
Completed NCT04112095 - Adherence With Continuous-dose Oral Contraceptive: Evaluation of Self-Selection and Use Phase 3
Recruiting NCT05521646 - Implementing Best Practice Postpartum Contraceptive Services Through a Quality Improvement Initiative N/A
Active, not recruiting NCT04291001 - Ovarian Function With ENG Implant and UPA Use Early Phase 1
Completed NCT04568980 - Assessment of Contraceptive Safety and Effectiveness in Cystic Fibrosis
Completed NCT03438682 - Real World Effectiveness and Safety of Hysteroscopic (Essure®) Compared to Laparoscopic Sterilization
Active, not recruiting NCT01948882 - Evaluation of Safety and Effectiveness of the Essure (Model ESS505) Device to Prevent Pregnancy in Women N/A
Enrolling by invitation NCT04997499 - Adolescent Subcutaneous (SQ) Injection Video Validation N/A
Recruiting NCT03589040 - Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant Phase 2
Completed NCT04463680 - Rifampin and the Contraceptive Implant Phase 4
Completed NCT03154125 - Sayana® Press Extension Study Phase 3
Withdrawn NCT03725358 - A Cluster-RCT to Increase the Uptake of LARCs Among Adolescent Females and Young Women in Cameroon. N/A
Completed NCT02957630 - "E4/DRSP Endocrine Function, Metabolic Control and Hemostasis Study" Phase 1/Phase 2
Completed NCT02718222 - Impact and Performance of Institutionalizing Immediate Post-partum IUD Services N/A
Completed NCT02456584 - Pharmacodynamics and Pharmacokinetics Study of Existing DMPA Contraceptive Methods Phase 1
Recruiting NCT02121067 - LNG-IUS at 2 Weeks Postpartum Phase 4
Terminated NCT02169869 - Immediate Postplacental IUD Insertion N/A
Recruiting NCT02292056 - Medication Safety and Contraceptive Counseling for Reproductive Aged Women With Psychiatric Conditions N/A
Withdrawn NCT01930994 - Kenya Sino-implant (II) PK Study N/A